Ellevest, Inc. Cure Vac N.V. Transaction History

Ellevest, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 18, 2022	SELL	$13.18 - $19.41 $197 - $291	-15 Reduced 22.73%	51 $1,000
Q1 2022 Apr 19, 2022	BUY	$14.73 - $35.25 $176 - $423	12 Added 22.22%	66 $1,000
Q4 2021 Jan 24, 2022	SELL	$33.72 - $48.22 $404 - $578	-12 Reduced 18.18%	54 $2,000
Q3 2021 Oct 19, 2021	BUY	$49.26 - $74.5 $3,251 - $4,917	66 New	66 $4,000
Q2 2021 Jul 13, 2021	SELL	$56.91 - $127.53 $14,796 - $33,157	-260 Closed	0 $0
Q4 2020 Feb 04, 2021	BUY	$46.76 - $136.27 $12,157 - $35,430	260 New	260 $21,000

12.3M

164K

117K

Ticker CVAC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,467,008
Market Cap $538M
Description
CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...

Get notified when there are updates to the investment portfolio of Ellevest, Inc., based on Form 13F filings with the SEC.

Stay updated on Ellevest, Inc. with notifications on news.